is there a shortage of semaglutide Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders Makers of compounded Wegovy, Ozempic

Any inconsistency between public claims and investigational status may be interpreted as evidence of consumer deception or misbranding

Gomez-Ramirez, M., Kelly, S

Over the years, the prevalence of T2D has risen sharply, driven by sedentary lifestyles, unhealthy dietary habits, and ageing populations (Khan et al

In addition to the neuropharmacological effects of GIPR antagonism, we also demonstrate that CNS GIPR KO prevents body weight gain under HFD challenge, supporting the role of CNS GIPR as a primary driver of body weight differences seen in the whole-body GIPR KO mouse 41

Plan your injection location around your post-injection activities